Labiana Health S.A. Total Liabilities
Labiana Health S.A. total liabilities. Based on the latest financial reports, Labiana Health S.A. (LAB) has total liabilities worth €52.79 Million EUR (≈ $61.71 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LAB financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Labiana Health S.A. (2021–2025)
Total liabilities of Labiana Health S.A. from 2021 to 2025. This chart illustrates how Labiana Health S.A.'s total liabilities have evolved over time, based on quarterly financial data.
Labiana Health S.A. Competitors by Total Liabilities
The table below lists competitors of Labiana Health S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Green Cross Medical Science Corporation
KQ:142280
|
Korea | ₩40.86 Billion |
|
Ananda Development Public Company Limited
BK:ANAN
|
Thailand | ฿17.27 Billion |
|
Mustek Ltd
JSE:MST
|
South Africa | ZAC2.48 Billion |
|
Kairous Acquisition Corp Ltd
NASDAQ:KACL
|
USA | $7.09 Million |
|
Mercury Corporation
KQ:100590
|
Korea | ₩30.42 Billion |
|
Advani Hotels & Resorts (India) Limited
NSE:ADVANIHOTR
|
India | Rs287.04 Million |
|
Senko Co. Ltd
KQ:347000
|
Korea | ₩14.15 Billion |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
USA | $44.67 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Labiana Health S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Labiana Health S.A.'s balance sheet.
Liquidity & Leverage Metrics
Labiana Health S.A. Total Liabilities Ratios Explained
Labiana Health S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Labiana Health S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Labiana Health S.A. (2021–2025)
The table below shows the annual total liabilities of Labiana Health S.A. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €52.79 Million ≈ $61.71 Million |
+6.78% |
| 2024-12-31 | €49.43 Million ≈ $57.79 Million |
-11.28% |
| 2023-12-31 | €55.72 Million ≈ $65.14 Million |
+5.06% |
| 2022-12-31 | €53.04 Million ≈ $62.00 Million |
-6.70% |
| 2021-12-31 | €56.84 Million ≈ $66.46 Million |
-- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more